Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Clinical trial NCT01324323 · COMPLETED

Trial details

NCT number: NCT01324323
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy Malignant Lymphoma

Start date: 2011-04-01
Primary completion: 2012-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.